IBA signs Proteus®ONE contract with Baptist Health’s Lynn Cancer Institute for a new proton therapy center in South Florida, USA
June 01 2022 - 12:00AM
IBA signs Proteus®ONE contract with Baptist Health’s Lynn Cancer
Institute for a new proton therapy center in South Florida,
USA
Louvain-La-Neuve, Belgium, 1 June, 2022
– IBA (Ion Beam Applications S.A., EURONEXT),
the world leader in particle accelerator technology and the world’s
leading provider of proton therapy solutions for the treatment of
cancer, today announces a contract with Eugene M.
& Christine E. Lynn Cancer Institute of Boca
Raton Regional Hospital, part of Baptist Health South
Florida, for the installation of its Proteus®ONE1 compact
proton therapy system. This project represents the second proton
therapy center for Baptist Health Cancer Care, which is
comprised of Miami Cancer Institute and Lynn Cancer
Institute, with the first having been installed at Miami
Cancer Institute as South Florida’s first proton therapy
center.
The contract includes a multi-year operation and
maintenance agreement, and it is expected that patients will start
being treated in 2024. The center will be located at the Boca
Raton Regional Hospital and it will be equipped with
IBA’s Proteus®ONE solution, including
Pencil Beam Scanning (PBS), Cone Beam Computed Tomography (CBCT)
and Hand Pendant with contextual menus for easy patient
positioning.
Olivier Legrain, Chief Executive Officer
of IBA, commented: “This new contract continues to
reinforce our leading position in the US market, marking our
20th proton therapy system in the region to date. We are
pleased to once again be partnering with Baptist Health’s
Cancer Care network to provide cancer patients with access to
the most advanced radiotherapy technology. After working with Miami
Cancer Institute, which has treated more than 1,000 patients to
date, we look forward to supporting Lynn Cancer Institute in
providing world-class cancer care.”
Dr. Michael Kasper, Medical Director of
Radiation Oncology at Lynn Cancer
Institute added: “At Lynn Cancer
Institute, our goal is to provide comprehensive and the most
innovative cancer care to our patients. Partnering with the leader
in proton therapy equipment manufacturing IBA was therefore the
logical choice for us. We are excited at the prospect of providing
our patients with this cutting-edge treatment.”
The typical end-user price for a Proteus®ONE
system with a 10-year maintenance contract ranges between 40-50
million US dollars. Revenue recognition on the contract will start
upon receipt of the downpayment and subject to building
permission.
***ENDS***
About IBA
IBA (Ion Beam Applications S.A.) is the world
leader in particle accelerator technology. The company is the
leading supplier of equipment and services in the field of proton
therapy, considered to be the most advanced form of radiation
therapy available today. IBA is also a leading player in the areas
of industrial sterilization, radiopharmaceuticals, and dosimetry.
Based in Louvain-la-Neuve, Belgium, the company employs
approximately 1,600 people worldwide. IBA is a certified B
Corporation (B Corp) meeting the highest verified social and
environmental performance standards.
IBA is listed on the pan-European stock exchange
EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).
More information can be found at:
www.iba-worldwide.com
About the Eugene M. & Christine E. Lynn Cancer
Institute
The Eugene M. & Christine E. Lynn Cancer
Institute is part of Baptist Health South Florida, the largest
healthcare organization in the region, with 11 hospitals, more than
23,000 employees, 4,000 physicians and 100 outpatient centers,
urgent care facilities and physician practices spanning across
Miami-Dade, Monroe, Broward and Palm Beach counties. Baptist
Health has internationally renowned centers of
excellence in cancer, cardiovascular care, orthopedics and
sports medicine, and neurosciences. In addition, it includes
Baptist Health Medical Group; Baptist Health Quality Network; and
Baptist Health Care On Demand, a virtual health platform. A
not-for-profit organization supported by philanthropy and committed
to its faith-based charitable mission of medical
excellence, Baptist Health has been
recognized by Fortune as one of the 100 Best Companies to Work For
in America and by Ethisphere as one of the World’s Most Ethical
Companies. For more information, visit BaptistHealth.net/Newsroom
and connect with us on Facebook, Instagram, Twitter and
LinkedIn.
About Baptist Health South
FloridaBaptist Health South Florida is the largest
healthcare organization in the region, with 12 hospitals, more than
24,000 employees, 4,000 physicians and 100 outpatient centers,
urgent care facilities and physician practices spanning across
Miami-Dade, Monroe, Broward and Palm Beach counties. Baptist
Health has internationally renowned centers of
excellence in cancer, cardiovascular care, orthopedics and
sports medicine, and neurosciences. In addition, it includes
Baptist Health Medical Group; Baptist Health Quality Network; and
Baptist Health Care On Demand, a virtual health platform. A
not-for-profit organization supported by philanthropy and committed
to its faith-based charitable mission of medical
excellence, Baptist Health has been
recognized by Fortune as one of the 100 Best Companies to Work For
in America and by Ethisphere as one of the World’s Most Ethical
Companies. For more information,
visit BaptistHealth.net/Newsroom and connect with us
on Facebook, Instagram, Twitter and LinkedIn.
###
CONTACTSIBASoumya
ChandramouliChief Financial Officer+32 10 475
890Investorrelations@iba-group.com
Olivier LechienCorporate
Communication Director+32 10 475 890communication@iba-group.com
Consilium Strategic
CommunicationsAmber Fennell, Angela Gray, Lucy
Featherstone+44 (0) 20 3709 5700IBA@consilium-comms.com
1 Proteus®ONE is the brand name of Proteus®235
- 20220601-IBA-BocaRaton-P1-EN-b
Ion Beam Applications (EU:IBAB)
Historical Stock Chart
From Apr 2024 to May 2024
Ion Beam Applications (EU:IBAB)
Historical Stock Chart
From May 2023 to May 2024